The Trivalent Story

The adoption rate of this will be radically diminished. I think we're down to hundred, 30 % of the people are willing to take another jab now. The european medicines agency has taken a different approach Historically, from the, from the fda and the c d c. In in e m a, the annual influence of accines get a short initial trial on ause theyy are annually outdated. Here in the states, there has been a decision that, so long as you use the same manufacturing process, you can switch out the anagens express. That would be akin to going from wohan one to a ba point five, a ninja uma.